Date: 2013-11-30 18:15:27

Genetic genealogy

Spinal muscular atrophy

SMN1

Survival of motor neuron

Antisense therapy

Amyotrophic lateral sclerosis

SMN2

Sense

Gideon Dreyfuss

Motor neurone disease

Biology

Genetics

Spinal Muscular Atrophy & ISIS-SMNRx Isis Pharmaceuticals is developing a drug to treat Spinal Muscular Atrophy (SMA). SMA is a genetic neuromuscular disease characterized by muscle atrophy and weakness. SMA is a leading

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 162,72 KB